Resveratrol induced neuroprotection is mediated via both estrogen receptor subtypes, ERα and ERβ

Neuroscience Letters

Volumn 548, Issue , 2013, Pages 217-221

  Saleh, Monique C ^a   Connell, Barry J ^a   Saleh, Tarek M ^a  

^a UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

Author keywords

Ischemia; MPP; PHTPP; Phytoestrogen; Reperfusion

Indexed keywords

1,3 BIS(4 HYDROXYPHENYL) 4 METHYL 5 [4 (2 [PIPERIDINYLETHOXY)PHENOL] 1N PYROZOLE DIHYDROCHLORIDE; 4 [2 PHENYL 5,7 BIS(TRIFLUOROMETHYL)PYROZOLO(1,5 A)PYRIMIDIN 3 YL]PHENOL; ANTIESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; RESVERATROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; MALE; NEUROPROTECTION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; REPERFUSION INJURY;

ISCHEMIA; MPP; PHTPP; PHYTOESTROGEN; REPERFUSION;

ANIMALS; BRAIN ISCHEMIA; CEREBRAL CORTEX; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; STILBENES; TREATMENT OUTCOME;

EID: 84880131859     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.05.057     Document Type: Article

References (31)

1. Agrawal M., Kumar V., Kashyap M.P., Khanna V.K., Randhawa G.S., Pant A.B. Ischemic insult induced apoptotic changes in PC12 cells: protection by trans resveratrol. Eur. J. Pharmacol. 2011, 666:5-11.
2. Agrawal M., Kumar V., Singh A.K., Kashyap M.P., Khanna V.K., Siddiqui M.A., Pant A.B. Trans-resveratrol protects ischemic PC12 cells by inhibiting the hypoxia associated transcription factors and increasing the levels of antioxidant defense enzymes. ACS Chem. Neurosci. 2013, 4:285-294.
3. Albarracin S.L., Stab B., Casas Z., Sutachan J.J., Samudio I., Gonzalez J., Gonzalo L., Capani F., Morales L., Barreto G.E. Effects of natural antioxidants in neurodegenerative disease. Nutr. Neurosci. 2012, 15:1-9.
4. Bowers J.L., Tyulmenkov V.V., Jernigan S.C., Klinge C.M. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors α and β. Endocrinology 2000, 141:3657-3667.
5. Chander V., Chopra K. Role of nitric oxide in resveratrol-induced renal protective effects of ischemic preconditioning. J. Vasc. Surg. 2005, 42:1198-1205.
6. Cowley S.M., Hoare S., Mosselman S., Parker M.G. Estrogen receptors α and β form heterodimers on DNA. J. Biol. Chem. 1997, 272:19858-19862.
7. Donnan G.A., Fisher M., Macleod M., Davis S.M. Stroke. Lancet 2008, 371:1612-1623.
8. Dubal D.B., Zhu H., Yu J., Rau S.W., Shughrue P.J., Merchenthaler I., Kindy M.S., Wise P.M. Estrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury. PNAS 2001, 98:1952-1957.
9. Dubal D.B., Rau S.W., Shughrue P.J., Zhu H., Yu J., Cashion A.B., Suzuki S., Gerhold L.M., Bottner M.B., Dubal S.B., Merchanthaler I., Kindy M.S., Wise P.M. Differential modulation of estrogen receptors (ERs) in ischemic brain injury: a role for ERα in estradiol-mediated protection against delayed cell death. Endocrinology 2006, 147:3076-3084.
10. Gao Z.B., Chen X.Q., Hu G.Y. Inhibition of excitatory synaptic transmission by trans-resveratrol in rat hippocampus. Brain Res. 2006, 1111:41-47.
11. Huang S.S., Tsai M.C., Chih C.L., Hung L.M., Tsai S.K. Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia. Life Sci. 2001, 69:1057-1065.
12. Hung L.M., Su M.J., Chen J.K. Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms. Free Radic. Biol. Med. 2004, 36:774-781.
13. Juan M.E., Maijo M., Planas J.M. Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC. J. Pharm. Biomed. Anal. 2010, 51:391-398.
14. Kennedy D.O., Wightman E.L., Reay J.L., Lietz G., Okello E.J., Wilde A., Haskell C.F. Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. Am. J. Clin. Nutr. 2010, 91:1590-1597.
15. Kiziltepe U., Turan N.N., Han U., Ulus A.T., Akar F. Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury. J. Vasc. Surg. 2004, 40:138-145.
16. Li X., Huang J., Yi P., Bambara R.A., Hilif R., Muyan M. Single-chain estrogen receptors (ERs) reveal that the ERα/β heterodimer emulates functions of the ERα dimer in genomic estrogen signaling pathways. Mol. Cell. Biol. 2004, 24:7681-7694.
17. Liu M.M., Albanese C., Anderson C.M., Hilty K., Webb P., Uht R.M., Price R.H., Prestell R.G., Kushner P.J. Opposing action of estrogen receptors α and β on cyclin D1 gene expression. J. Biol. Chem. 2002, 277:24353-24360.
18. Matthews J., Gustafsson J.A. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol. Interventions 2003, 3:281-292.
19. Monroe D.G., Secreto F.J., Subramaniam M., Getz B.J., Khosla S., Spelsberg T.C. Estrogen receptor α and β heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells. Mol. Endocrinol. 2005, 19:1555-1568.
20. Nakata R., Takahashi S., Inoue H. Recent advances in the study on resveratrol. Biol. Pharm. Bull. 2012, 35:273-279.
21. Paravicini T.M., Miller A., Drummond G.R., Sobey C.G. Flow-induced cerebral vasodilatation in vivo involves activation of phosphatidylinositol-3 kinase, NADPH-oxidase, and nitric oxide synthase. J. Cereb. Blood Flow Metab. 2006, 26:836-845.
22. Paulmurugan R., Tamrazi A., Massoud T.F., Katzenellenbogen J.A., Gambhir S.S. In vitro and in vivo molecular imaging of estrogen receptor α and β homo- and heterodimerization: exploration of new modes of receptor regulation. Mol. Endocrinol. 2011, 25:2029-2040.
23. The Rat Brain in Stereotaxic Coordinates 1997, Academic Press, San Diego. G. Paxinos, C. Watson (Eds.).
24. Powell E., Shanie E., Brinkman A., Li J., Keles S., Wisinski K.B., Huang W., Xu W. Identification of estrogen receptor dimer selective ligands reveals growth-inhibitory effects on cells that co-express ERα and ERβ. PLoS ONE 2012, 7:e30993.
25. Saleh M.C., Connell B.J., Saleh T.M. Resveratrol preconditioning induces cellular stress proteins and is mediated via NMDA and estrogen receptors. Neuroscience 2010, 166:445-454.
26. Shin J.A., Lee H., Lim Y.K., Koh Y., Choi J.H., Park E.M. Therapeutic effects of resveratrol during acute periods following experimental ischemic stroke. J. Neuroimmunol. 2010, 227:93-100.
27. Shughrue P.J., Lane M.V., Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J. Comp. Neurol. 1997, 388:507-525.
28. Sun A.Y., Wang Q., Simonyi A., Sun G.Y. Resveratrol as a therapeutic agent for neurodegenerative diseases. Mol. Neurobiol. 2010, 41:375-383.
29. Virgili M., Contestabile A. Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats. Neurosci. Lett. 2000, 281:123-126.
30. Wight R.D., Tull C.A., Deel M.W., Stroope B.L., Eubanks A.G., Chavis J.A., Drew P.D., Hensley L.L. Resveratrol effects on astrocyte function: relevance to neurodegenerative diseases. Biochem. Biophys. Res. Commun. 2012, 426:112-115.
31. Yu C., Shin Y.G., Chow A., Li Y., Kosmeder J.W., Lee Y.S., Hirschelman W.H., Pezzuto J.M., Mehta R.G., van Breemen R.B. Human, rat and mouse metabolism of resveratrol. Pharm. Res. 2002, 19:1907-1914.